400-0512-686

β2- microglobulin detection kit (latex enhanced immune nephelometry)

For in vitro quantitative determination of serum microglobulin levels β2-/p>

【Clinical significance】

β2-- microglobulin (β2-MG) is mainly used for the evaluation of renal function. Due to reduction of tubular reabsorption, β2-MG concentration is high in urine and normal in serum, which indicate renal tubular disease and chronic pyelonephritis; Due to reduction of glomerular filtration, β2-MG concentration is high in serum and normal in urine, which indicates acute or chronic nephritis.

【Test principle】

Mix serum (containing β2-MG) and reagent (goat anti-human β2-MG induced a polyclonal antibody Sensitive Nano microspheres) to form insoluble immune complexes, which increases the turbidity of reaction solution.
Measure absorbance by spectrophotometer at the wavelength of 546nm.
The turbidity reflects the concentration of β2-MG in the sample, which can be read out by a working curve calibrated by standard serum.

【Storage conditions and validity】

Stable for one year when stored at 2 ~ 8 ℃ in the dark (freeze prohibited),
Stable at 2~8 °C for one month after initial use.

【Note】

1. The amount of reagent and sample might need to increase or decrease under the same proportion to meet the requirement of biochemical analytical instruments.
2. When the samples β2-MG concentration exceeds 18.0mg/L, dilute with 0.9% saline for a maximum of 10 times and test again.
3. 0.05% Proclin-300 is contained as a preservative. NO SWALLOW and avoid contact with skin and mucous membranes. If you accidentally contact with skin or mucous membranes, rinse immediately with plenty of water and go to hospital for treatment.
4. Sheep-derived antibodies are included, which is a potential risk of infection. NO SWALLOW and avoid contact with skin and mucous membranes.




Top

Earlier
April 2014

Lumigenex receives CFDA approval for four POCT immunoassay kits to help physicians quickly and accurately diagnose heart diseases.

March 2014

Lumigenex receives CFDA approval for five immunoassay reagents adaptable to most chemical analyzers.

February 2014

Lumigenex received CFDA approval for time-resolved fluorescence immunochromatographic analyzer.

January 2014

Dr. He Aimin was named "National Thousand Talents Program"

December 2013

Lumigenex access to "high-tech enterprises in Jiangsu Province" title.

September 2013

Lumigenex passed The first Food and Drug Administration by the Suzhou Municipal Quality Management System Assessment.